Dr. Reddy's Laboratories Ltd. (DRREDDY)
NSE
1,151.00
+6.80 (+0.59%)
Closed
Sep 8, 2026
Day's Range
1,144.001,154.50
52 wk Range
1,101.001,414.90
Financial Statements - DRREDDY - Dr. Reddy's Laboratories Ltd.
Revenue
335.93B▲ 3.2%
Net Income
42.46B▼ 25.8%Net Margin 12.6%
EBITDA
74.58B▼ 18.9%
Free Cash Flow
18.33B▲ 52.4%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 335.93B | 325.53B | 279.16B | 245.87B | 214.39B | 189.72B |
| Cost of Goods | 158.66B | 135.10B | 115.55B | 106.53B | 100.55B | 86.64B |
| Gross Profit | 177.26B | 190.42B | 163.60B | 139.34B | 113.84B | 103.07B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 50.12B | 72.01B | 65.30B | 59.05B | 35.91B | 32.91B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 4.70B | 4.92B | 5.99B | 1.56B | -3.62B | -6.35B |
| Pre Tax Income | 54.81B | 76.78B | 71.87B | 60.36B | 32.29B | 26.41B |
| Income Tax | 12.35B | 19.53B | 16.18B | 15.30B | 8.73B | 9.17B |
| Net Income | 42.46B | 57.24B | 55.68B | 45.06B | 23.56B | 17.23B |
| EPS Basic | 51.48 | 67.89 | 66.93 | 54.286 | 28.416 | 20.788 |
| EPS Diluted | 51.42 | 67.79 | 66.804 | 54.17 | 28.338 | 20.73 |
| Basic Shares Outstanding | 832.44M | 832.97M | 831.96M | 830.17M | 829.39M | 829.22M |
| Diluted Shares Outstanding | 832.44M | 832.97M | 831.96M | 830.17M | 829.39M | 829.22M |
| Ebit | 58.55B | 79.61B | 73.58B | 61.79B | 33.25B | 27.38B |
| Ebitda | 74.58B | 91.96B | 82.57B | 73.24B | 49.41B | 47.01B |
| Net Income Continuous Operations | 42.46B | 57.24B | 55.68B | 45.06B | 23.56B | 17.23B |
| Minority Interests | 384M | -701M | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
